Format

Send to

Choose Destination
Blood. 2018 Feb 15;131(7):830-835. doi: 10.1182/blood-2017-07-796151. Epub 2018 Jan 5.

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.

Author information

1
Department of Medicine and.
2
Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
3
Centre for Innovation, Canadian Blood Services, Toronto, ON, Canada.
4
Division of Hematology and Transfusion Medicine, Department of Laboratory Medicine, Lund University, Lund, Sweden.
5
Department of Clinical Immunology and Transfusion Medicine, Laboratory Medicine, Office of Medical Services, Region Skåne, Lund, Sweden.
6
Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
7
Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
8
Department of Clinical Pathology, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
9
Department of Laboratory Medicine, St. Michael's Hospital, Toronto, ON, Canada.
10
Institut Universitaire de Cardiologie et Pneumologie de Québec and CHU de Québec and Hôpitaux Enfant-Jésus et Saint-Sacrement, Québec City, QC, Canada.
11
Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, ON, Canada.
12
Canadian Blood Services, Toronto, ON, Canada.
13
Department of Transfusion Medicine, Pediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON, Canada.
14
Pediatric Hematology, Immunology, Rheumatology, and Infectious Diseases, Emma Children's Hospital, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center